Nurse Practitioner, Adult Health · Boston, MA
NPI
1578901708
Since 2013
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
55 Fruit St, Mass General-Lunder 9-Inpatient NP Service
Boston, MA, 02114
Phone (857) 238-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
290 services
Medicare patients, 2024
99
Average age 75
Drug cost, 2024
$2.7M
617 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara E Stevens was code 99215 (office e&m - established), 208 times for 95 patients. In total Sara E Stevens billed 290 services in 3 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 208 | 95 | $97.52 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 58 | 36 | $11.74 | $681 |
| 99215 Office E&M - Established | Office | 13 | 11 | $118.70 | $1,543 |
By year: 2022 $5,615 for 66 services; 2023 $12K for 130 services; 2024 $23K for 290 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sara E Stevens prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 58 prescriptions and refills. In total Sara E Stevens wrote 617 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 58 | 58 | 12 | $956K |
| Dexamethasone Generic | 57 | 59 | 33 | $489 |
| Prochlorperazine Maleate Generic | 38 | 38 | 29 | $526 |
| Ondansetron Hcl Generic | 27 | 27 | 23 | $315 |
| Oxycodone Hcl Generic | 24 | 24 | 17 | $277 |
| Lorbrena Lorlatinib | 20 | 20 | Under 11 | $418K |
| Prednisone Generic | 20 | 20 | 15 | $55.4 |
| Omeprazole Generic | 18 | 36 | Under 11 | $109 |
| Eliquis Apixaban | 16 | 22 | Under 11 | $13K |
| Nystatin Generic | 15 | 15 | Under 11 | $277 |
| Gabapentin Generic | 13 | 19 | Under 11 | $164 |
| Xalkori Crizotinib | 13 | 13 | Under 11 | $160K |
| Alecensa Alectinib Hcl | 12 | 12 | Under 11 | $230K |
| Tabrecta Capmatinib Hydrochloride | 12 | 12 | Under 11 | $210K |
| Retevmo Selpercatinib | 12 | 12 | Under 11 | $274K |
Brand drugs: - claims; generic drugs: 411 claims; opioid claims: 51.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sara E Stevens were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.